10x Genomics, Inc.

TXG

$11.60

Name : 10x Genomics, Inc.

Sector : Healthcare

Industry: Health Information Services

Mark. Cap: $1,444,087,936.00

EPSttm : -0.7

10x Genomics, Inc.

$11.60

8.23%

$1.04

Float Short %

15.71

Margin Of Safety %

-19

Put/Call OI Ratio

0.26

EPS Next Q Diff

-0.32

EPS Last/This Y

1.6

EPS This/Next Y

-0.25

Price

11.59

Target Price

14.87

Analyst Recom

2.25

Performance Q

-4.13

Relative Volume

0.99

Beta

2.12

Ticker: TXG

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	TXG	13.94	0.22	0.13	11093
2025-09-09	TXG	13.51	0.23	0.65	11136
2025-09-10	TXG	12.59	0.22	0.06	11100
2025-09-11	TXG	13.07	0.22	0.63	11156
2025-09-12	TXG	12.65	0.24	0.74	11356
2025-09-15	TXG	13.35	0.23	0.06	11398
2025-09-16	TXG	13.12	0.23	0.16	11381
2025-09-17	TXG	12.86	0.23422448316917	0.0069204152249135	11403
2025-09-18	TXG	13.28	0.21	0.03	11949
2025-09-22	TXG	13.03	0.20	0.29	10678
2025-09-23	TXG	12.49	0.20	0.50	10790
2025-09-24	TXG	12.06	0.21	1.45	10930
2025-09-25	TXG	11.94	0.27	0.14	11876
2025-09-26	TXG	11.72	0.27	0.01	12019
2025-09-29	TXG	11.34	0.29	0.32	11393
2025-09-30	TXG	11.7	0.29	2.12	11437
2025-10-01	TXG	12.4	0.30	2.14	11686
2025-10-02	TXG	12.31	0.27	0.10	11560
2025-10-03	TXG	12.74	0.27	0.16	11762
2025-10-06	TXG	12.64	0.27	0.27	11722
2025-10-07	TXG	11.59	0.26	0.25	11715
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	TXG	13.93	-358.4	-89.6	0.09
2025-09-09	TXG	13.50	-358.4	-83.6	0.09
2025-09-10	TXG	12.59	-358.4	-75.6	0.09
2025-09-11	TXG	13.06	-358.4	-98.3	0.09
2025-09-12	TXG	12.65	-358.4	-83.2	0.09
2025-09-15	TXG	13.35	-358.4	-102.4	0.09
2025-09-16	TXG	13.13	-358.4	-86.5	0.09
2025-09-17	TXG	12.84	-358.4	-85.3	0.09
2025-09-18	TXG	13.25	-358.4	-96.7	0.09
2025-09-19	TXG	13.01	-358.4	-86.0	0.09
2025-09-22	TXG	13.04	-358.4	-90.0	0.09
2025-09-23	TXG	12.48	-358.4	-80.8	0.09
2025-09-24	TXG	12.06	-358.4	-82.5	0.09
2025-09-25	TXG	11.95	-358.4	-88.1	0.09
2025-09-26	TXG	11.72	-358.4	-85.8	0.09
2025-09-29	TXG	11.34	-358.4	-82.9	0.09
2025-09-30	TXG	11.70	-358.4	-97.3	0.09
2025-10-01	TXG	12.40	-358.4	-103.8	0.09
2025-10-02	TXG	12.35	-358.4	-89.4	0.09
2025-10-03	TXG	12.74	-358.4	-97.8	0.09
2025-10-06	TXG	12.64	-358.4	-96.1	0.09
2025-10-07	TXG	11.59	-358.4	-71.8	0.09
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	TXG	-0.42	6.31	12.36
2025-09-09	TXG	-0.42	6.31	12.36
2025-09-10	TXG	-0.42	6.31	12.36
2025-09-11	TXG	-0.42	6.31	12.44
2025-09-12	TXG	-0.42	6.31	12.44
2025-09-15	TXG	-0.42	6.17	12.44
2025-09-16	TXG	-0.42	6.17	12.44
2025-09-17	TXG	-0.42	6.17	12.44
2025-09-18	TXG	-0.42	6.17	12.44
2025-09-19	TXG	-0.42	6.17	12.44
2025-09-22	TXG	-0.42	6.31	12.44
2025-09-23	TXG	-0.42	6.31	12.44
2025-09-24	TXG	-0.42	6.31	12.44
2025-09-25	TXG	-0.42	6.31	15.71
2025-09-26	TXG	-0.42	6.31	15.71
2025-09-29	TXG	-0.42	6.30	15.71
2025-09-30	TXG	-0.42	6.30	15.71
2025-10-01	TXG	-0.42	6.30	15.71
2025-10-02	TXG	-0.42	6.30	15.71
2025-10-03	TXG	-0.42	6.30	15.71
2025-10-06	TXG	-0.42	5.71	15.71
2025-10-07	TXG	-0.42	5.71	15.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.28

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.04

Insider Transactions

-0.42

Institutional Transactions

5.71

Beta

2.12

Average Sales Estimate Current Quarter

142

Average Sales Estimate Next Quarter

150

Fair Value

9.41

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.5

Max Drawdown 5-Year %

-96.5

Target Price

14.87

P/E

Forward P/E

PEG

P/S

2.24

P/B

1.87

P/Free Cash Flow

25.39

EPS

-0.7

Average EPS Est. Cur. Y

0.09

EPS Next Y. (Est.)

-0.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.13

Relative Volume

0.99

Return on Equity vs Sector %

-36.1

Return on Equity vs Industry %

-26.3

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.16

EBIT Estimation

-71.8

10x Genomics, Inc.

Sector: Healthcare

Industry: Health Information Services

Employees: 1306

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today

news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance

stock history TXG – 10x Genomics, Inc. invest stock market

stock prices TXG premarket after hours

ticker TXG fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: TXG

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y